Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2019 for Novelion Therapeutics Inc., €220. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Linda Buono: trading record in brief
Linda Buono discloses dealings in Novelion Therapeutics Inc. to SEDI. Between 29 November 2016 and 9 May 2019, the trades on record add up to 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 May 2019, reports an option exercise of €220 in Novelion Therapeutics Inc. The median gap between a trade and its publication by SEDI is 2 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Linda Buono
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
273 shares@ CA$1.2220.2% of flowCommon SharesTSXSEDI:3367002
77 shares@ CA$1.225.7% of flowCommon SharesTSXSEDI:3367003
273 sharesCommon SharesTSXSEDI:3182173
80 shares@ CA$4.2620.5% of flowCommon SharesTSXSEDI:3182174
Common SharesTSXSEDI:3006402
274 sharesCommon SharesTSXSEDI:3006413
93 shares@ CA$9.42100.0% of flowCommon SharesTSXSEDI:3006414
7 of 7 declarations
